Skip to main content

Table 5 P values for each inflammatory parameter, pooled across all cognitive tests

From: Improved neurocognitive functions correlate with reduced inflammatory burden in atrial fibrillation patients treated with intensive cholesterol lowering therapy

C1-inh 0.22 C3bc 0.77 C4bc 0.79 Properdin 0.56 TCC 0.93 PPH0.29 ETP 0.19
Eotaxin0.52 FGF 0.17 G-CSF 0.47 GM-CSF 0.41 IFNγ 0.19 MIP-1α 0.37 MIP-1β 0.01
IL-1β 0.18 IL-1RA 0.01 IL-2 0.04 IL-4 0.25 IL-5 0.11 IL-6 0.55 IL-7 0.69
IL-8 0.45 IL-9 0.05 IL-10 0.38 IL-12 0.01 IL-13 0.10 IL-15 0.56 IL-17 0.36
MCP-1 0.67 PAI 0.63 PDGF 0.44 RANTES 0.47 TNF-α 0.15 VEGF 0.40 IP-10 0.49
  1. C1-inh, C1-inhibitor; ETP, endogenous thrombin potential; FGF, fibroblast growth factor; G-CSF, granulocyte colony-stimulating factor; GM-CSF, granulocyte-macrophage colony-stimulating factor; IFNγ, interferon-γ; IL, interleukin; IL-1RA, interleukin-1 receptor antagonist; IL-1β, interleukin-1β, IP-10 (also known as C-X-C motif chemokine 10or CXCL10), interferon gamma-induced protein 10; MCP-1 (also known as CCL2), monocyte chemotactic protein-1; MIP-1α (also known as CCL3), macrophage inflammatory protein-1α; MIP-1β (also known as CCL4), macrophage inflammatory protein-1β; PAI, plasminogen activator inhibitor; PDGF, platelet-derived growth factor; PPH, plasmin peak height; RANTES (also known as CCL5), regulated on activation, normal T cell expressed and secreted; TCC, terminal complement complex; TNF-α, tumor necrosis factor-α; VEGF, vascular endothelial growth factor.